High Sierra Technologies, Inc. (HSTI)
USD 0.25
(0.0%)
USD 0.25
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -181.97 Thousand USD | 17.5% |
| 2021 | -220.57 Thousand USD | 0.89% |
| 2020 | -222.56 Thousand USD | 50.2% |
| 2019 | -446.94 Thousand USD | -1182.85% |
| 2018 | -34.84 Thousand USD | -57.5% |
| 2017 | -22.11 Thousand USD | -7.07% |
| 2016 | -20.66 Thousand USD | 40.7% |
| 2015 | -34.84 Thousand USD | -32.06% |
| 2014 | -26.38 Thousand USD | -22.42% |
| 2013 | -21.54 Thousand USD | 8.79% |
| 2012 | -23.62 Thousand USD | 6.41% |
| 2011 | -22.16 Thousand USD | -53.31% |
| 2010 | -18.05 Thousand USD | 5.7% |
| 2009 | -18.66 Thousand USD | 3.95% |
| 2008 | -17.89 Thousand USD | 3.0% |
| 2007 | -18.74 Thousand USD | 37.05% |
| 2006 | -29.77 Thousand USD | -237.82% |
| 2005 | -8813.00 USD | 6.09% |
| 2004 | -8761.00 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | -64.08 Thousand USD | -50.1% |
| 2023 Q2 | -67.98 Thousand USD | -6.08% |
| 2023 Q3 | -63.07 Thousand USD | 7.22% |
| 2022 Q1 | -89.09 Thousand USD | -775.18% |
| 2022 FY | - USD | 17.5% |
| 2022 Q4 | -42.69 Thousand USD | -74.65% |
| 2022 Q3 | -24.44 Thousand USD | 5.03% |
| 2022 Q2 | -25.73 Thousand USD | 71.11% |
| 2021 Q1 | -61.41 Thousand USD | 65.68% |
| 2021 Q4 | -10.18 Thousand USD | 90.79% |
| 2021 FY | - USD | 0.89% |
| 2021 Q2 | -38.38 Thousand USD | 37.5% |
| 2021 Q3 | -110.59 Thousand USD | -188.09% |
| 2020 Q1 | -8602.00 USD | -116.42% |
| 2020 Q3 | -24.33 Thousand USD | -128.3% |
| 2020 Q2 | -10.65 Thousand USD | -23.89% |
| 2020 FY | - USD | 50.2% |
| 2020 Q4 | -178.97 Thousand USD | -635.6% |
| 2019 FY | - USD | -1182.85% |
| 2019 Q3 | -167.49 Thousand USD | 39.09% |
| 2019 Q1 | -56.82 Thousand USD | -12.31% |
| 2019 Q2 | -274.99 Thousand USD | -383.91% |
| 2019 Q4 | 52.38 Thousand USD | 131.27% |
| 2018 Q4 | -50.59 Thousand USD | -187.47% |
| 2018 Q1 | -90.00 USD | 97.36% |
| 2018 Q3 | 57.84 Thousand USD | 700.9% |
| 2018 Q2 | -9627.00 USD | -10596.67% |
| 2018 FY | - USD | -57.5% |
| 2017 Q3 | -3666.00 USD | 67.67% |
| 2017 FY | - USD | -7.07% |
| 2017 Q4 | -3414.00 USD | 6.87% |
| 2017 Q2 | -11.33 Thousand USD | -206.29% |
| 2017 Q1 | -3702.00 USD | -1.65% |
| 2016 Q4 | -3642.00 USD | 31.71% |
| 2016 Q3 | -5333.00 USD | 42.61% |
| 2016 FY | - USD | 40.7% |
| 2016 Q2 | -9293.00 USD | -287.85% |
| 2016 Q1 | -2396.00 USD | 56.74% |
| 2015 Q2 | -17.46 Thousand USD | -328.66% |
| 2015 Q1 | -4075.00 USD | 31.82% |
| 2015 Q4 | -5538.00 USD | 28.65% |
| 2015 FY | - USD | -32.06% |
| 2015 Q3 | -7762.00 USD | 55.56% |
| 2014 FY | - USD | -22.42% |
| 2014 Q4 | -5977.00 USD | 20.01% |
| 2014 Q3 | -7472.00 USD | -115.52% |
| 2014 Q2 | -3467.00 USD | 52.05% |
| 2014 Q1 | -7230.00 USD | -45.27% |
| 2013 Q1 | -2282.00 USD | 56.13% |
| 2013 Q2 | -10.81 Thousand USD | -373.75% |
| 2013 Q3 | -5719.00 USD | 47.1% |
| 2013 Q4 | -4977.00 USD | 12.97% |
| 2013 FY | - USD | 8.79% |
| 2012 FY | - USD | 6.41% |
| 2012 Q3 | -6735.00 USD | -33.23% |
| 2012 Q2 | -5055.00 USD | 12.45% |
| 2012 Q4 | -5202.00 USD | 22.76% |
| 2012 Q1 | -5774.00 USD | 8.54% |
| 2011 Q1 | -7055.00 USD | -80.11% |
| 2011 Q2 | -4670.00 USD | 33.81% |
| 2011 Q3 | -4130.00 USD | 11.56% |
| 2011 FY | - USD | -53.31% |
| 2011 Q4 | -6313.00 USD | -52.86% |
| 2010 Q3 | -3204.00 USD | 52.18% |
| 2010 Q2 | -6700.00 USD | -58.47% |
| 2010 Q1 | -4228.00 USD | -11.97% |
| 2010 FY | - USD | 5.7% |
| 2010 Q4 | -3917.00 USD | -22.25% |
| 2009 Q3 | -3384.00 USD | 33.19% |
| 2009 Q2 | -5065.00 USD | 21.34% |
| 2009 Q1 | -6439.00 USD | -111.88% |
| 2009 Q4 | -3776.00 USD | -11.58% |
| 2009 FY | - USD | 3.95% |
| 2008 Q1 | -5136.00 USD | -70.18% |
| 2008 Q4 | -3039.00 USD | 1.07% |
| 2008 Q3 | -3072.00 USD | 53.79% |
| 2008 Q2 | -6648.00 USD | -29.44% |
| 2008 FY | - USD | 3.0% |
| 2007 Q1 | -6756.00 USD | -192.97% |
| 2007 Q2 | -8467.00 USD | -25.33% |
| 2007 FY | - USD | 37.05% |
| 2007 Q3 | -2896.00 USD | 65.8% |
| 2007 Q4 | -3018.00 USD | -4.21% |
| 2006 Q4 | -2306.00 USD | 72.89% |
| 2006 Q3 | -8506.00 USD | 53.4% |
| 2006 Q1 | -1017.00 USD | 75.37% |
| 2006 FY | - USD | -237.82% |
| 2006 Q2 | -18.25 Thousand USD | -1694.79% |
| 2005 Q1 | -1364.00 USD | 0.0% |
| 2005 Q2 | -5565.00 USD | -307.99% |
| 2005 Q3 | -1359.00 USD | 75.58% |
| 2005 Q4 | -4129.00 USD | -203.83% |
| 2005 FY | - USD | 6.09% |
| 2004 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| BioQuest Corp. | -33.57 USD | -541964.343% |
| GSRX Industries Inc. | - USD | Infinity% |
| Instadose Pharma Corp. | - USD | Infinity% |